Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, What discussions he has had with the (a) National Institute for Health and Care Excellence and (b) Medicines and Healthcare products Regulatory Agency on rapid managed access to new medicines with an Innovation Passport under the Innovative Licensing and Access Pathway.

The Department regularly discusses a range of issues with colleagues in the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE). The Department, NICE and MHRA are currently working together with other Innovative Licensing and Access Pathway (ILAP) partners to refresh the existing operating model for ILAP to ensure that it is delivering on the ambition to support rapid patient access to transformative new medicines.